1Braunwald E. Biomarkers in heart failure. N Engl J Med,2008, 358:2148-2159.
2Stoupakis G, Klapholz M. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure. Heart Dis, 2003, 5:215-223.
3Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretie peptide in the emergency diagnosis of heart failure. N Engl J Med, 2002, 347 : 161-167.
4Januzzi JL, Camargo CA, Anwaruddin S, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol, 2005, 95:948-954.
6Silvers SM, Howell JM, Kosowsky JM, et al. Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute heart failure syndromes. Ann Emerg Med, 2007, 49:627-669.
8Richards AM, Nicholls MG, Espiner EA, et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation, 2003, 107:2786-2792.
9Koglin J, Pehlivanli S, Schwaiblmair M, et al. Role of brain na- triureic peptide in risk stratification of patient with congestive heart failure. J Am Coil Cardiol, 2001,38:1934-1941.
10Groenning BA, Raymond I, Hildebrandt PR, et al. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population. Heart, 2004, 90: 297 -303.
2Pearson TA, Mensah GA, Hong Y, et al. CDC/AHA Workshop on markers of inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice : Overview. Circulation, 2004,110 : e543-544.
3Myers GL,Rifai N,Tracy RP,et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease : Application to Clinical and Public Health Practice: report from the laboratory science discussion group. Circulation ,200d, 110 :e545-549.
4Smith SC Jr, Anderson JL, Cannon RO 3rd, et al. CDC/AHA Workshop on Markers of inflammation and Cardiovascular Disease:Application to Clinical And Public Health Practice: report from the clinical practice discussion group. Circulation,2004, 110 : e550-553.
5Fortmann SP, Ford E, Criqui MH, et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease : Application to Clinical and Public Health Practice: report from the population science discussion group. Circulation,2004, 110 : e554-559.
6Biasucci LM, CDC, AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease : Application to Clinical and Public Health practice: clinical use of inflammatory markers in Patients with cardiovascular diseases : a background paper.Circulation ,2004, 110 :e560-567.
7Wilson PW, CDC, AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease:Application to Clinical and Public Health Practice: ability of inflammatory markers to predict disease in asymptomatic patients: a background paper. Circulation,2004,110:e568-571.
8Roberts WL, CDC, AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease. Application to Clinical and Public Health Practice. laboratory tests available to assess inflammation-performance and standardization: a background paper.Circulation, 2004,110 :e572-578.
9Morrow DA, Braunwald E. Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy. Circulation, 2003,108:250-252.
10Apple FS. Clinical and analytical standardization issues confronting cardiac troponin I. Clin Chem, 1999,45:18-20.
4Malyutina S, Bobak M, Kurilovitch S, et al. Trends in alcohol in- take by education and marital status in urban population in Russia between the mid 1980s and the mid 1990s [J]. Alcohol Alcohol, 2004 ,39( 1 ) :64-69.
5Sedy J, Zicha J, Kunes J, et al. Mechanisms of neurogenie pulmo- nary edema development [ J ]. Physiol Res, 2008,57 (4) :499-506.
6Gajic O, Rana R, Winters JL, et al. Transfusion-related acute lung injury in the critically ill: prospective nested case-control study[J]. AmJ RespirCrit CareMed, 2007,176(9) :886-891.
7Bechara RI, Brown LA, Roman J, et al. Transforming growth factor betal expression and activation is increased in the alcoholic rat lung[J]. AmJRespirCritCare Med, 2004,170(2):188-194.
8Devicre J, Content J, Dcnys C, et al. High interlcukin-6 serum lev- els and increased production by leucocytes in alcoholic liver cirrho- sis. Correlation with IgA serum levels and lymphokines production [J]. ClinExphnmunol, 1989,77(2) :221-225.
9Marshall RP, Wehl) S, Belllngan GJ, et al. Anglotensln converting enzyme insertion/deletion polymorphismis associated with suseepti- bility and outcome in acute respiratorydistress syndrome [ J]. Am J Respir Crit Care Med, 2002,166(5 ) :646-650.
10Fernandes CJ Jr, Akamine N, Knobel E. Myocardial depression in sepsis [J]. Shock, 2008, Suppl 1 : 14-17.
